Keryx Biopharmaceuticals competitors

Keryx Biopharmaceuticals Competitors include NovaBay Pharmaceuticals, UCB, LGC Biosearch Technologies and Loxo Oncology.
Add company...
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development of products for the treatment of renal diseases.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
UCB
UCB
Patients are at the center of everything we do. At UCB, we are Inspired by patients. Driven by science.
LGC Biosearch Technologies
LGC Biosearch Technologies
LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.
Loxo Oncology
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
Founding Date
Founding Date
1998
Founding Date
2000
Founding Date
1928
Founding Date
1842
Founding Date
2013
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
New York, US HQ
Boston, US
Locations
Emeryville, US HQ
Locations
Anderlecht, BE HQ
Locations
Teddington, GB HQ
Locations
Stamford, US HQ
South San Francisco, US
Employees
Employees
N/A
Employees
21
Employees
7,5001% decrease
Employees
N/A
Employees
5926% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
26.5 m
Valuation ($)
13.3 b
Valuation ($)
N/A
Valuation ($)
7.2 b
Twitter followers
Twitter followers
391
Twitter followers
2.2 k
Twitter followers
2.8 k
Twitter followers
2.4 k
Twitter followers
46

Financial

Revenue (est.)
Revenue (est.)
$60.6m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£131.2m (FY, 2018)
Revenue (est.)
N/A
Net income
Net income
($163.4m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
£9.2m (FY, 2018)
Net income
($148.9m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 13.6m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 57m
For sources of this data, please see the company profileDownload Excel

View company profiles

NovaBay Pharmaceuticals
HQ
Emeryville, US
Employees
21

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

View company
UCB
HQ
Anderlecht, BE
Employees
7,500↓ 1% decrease

Patients are at the center of everything we do. At UCB, we are Inspired by patients. Driven by science.

View company
LGC Biosearch Technologies
HQ
Teddington, GB

LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.

View company
Loxo Oncology
HQ
Stamford, US
Employees
59↑ 26% increase

Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.

View company